 Bobby Boyanton Jr
Concepts (200)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 5 | 2022 | 46 | 2.480 |
Why?
| | Molecular Diagnostic Techniques | 6 | 2019 | 33 | 2.170 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2019 | 181 | 1.590 |
Why?
| | Respiratory Tract Infections | 3 | 2024 | 76 | 1.440 |
Why?
| | Antigens, Protozoan | 2 | 2017 | 10 | 1.160 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 14 | 1.160 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2020 | 74 | 1.120 |
Why?
| | Streptococcus agalactiae | 3 | 2020 | 13 | 1.100 |
Why?
| | Bacteriological Techniques | 4 | 2015 | 42 | 1.080 |
Why?
| | Diagnostic Tests, Routine | 2 | 2017 | 28 | 1.010 |
Why?
| | Pseudohypoaldosteronism | 1 | 2024 | 5 | 0.950 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2024 | 9 | 0.950 |
Why?
| | Coinfection | 1 | 2024 | 42 | 0.890 |
Why?
| | Pharyngitis | 1 | 2022 | 16 | 0.840 |
Why?
| | Mycoplasma pneumoniae | 2 | 2024 | 4 | 0.820 |
Why?
| | Infection Control | 1 | 2022 | 47 | 0.770 |
Why?
| | Pandemics | 2 | 2024 | 567 | 0.740 |
Why?
| | Child, Preschool | 11 | 2024 | 3879 | 0.660 |
Why?
| | Carrier State | 1 | 2019 | 10 | 0.650 |
Why?
| | Staphylococcal Infections | 1 | 2022 | 269 | 0.640 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2017 | 1 | 0.590 |
Why?
| | BK Virus | 1 | 2017 | 4 | 0.580 |
Why?
| | Polyomavirus Infections | 1 | 2017 | 10 | 0.580 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 46 | 0.570 |
Why?
| | Travel | 1 | 2017 | 37 | 0.570 |
Why?
| | Transplants | 1 | 2017 | 19 | 0.570 |
Why?
| | Sensitivity and Specificity | 7 | 2019 | 858 | 0.560 |
Why?
| | Vagina | 2 | 2019 | 44 | 0.550 |
Why?
| | Humans | 30 | 2024 | 49929 | 0.540 |
Why?
| | Child | 12 | 2024 | 6849 | 0.530 |
Why?
| | Infant | 9 | 2022 | 3575 | 0.530 |
Why?
| | Pasteurella multocida | 1 | 2015 | 1 | 0.520 |
Why?
| | Pasteurella Infections | 1 | 2015 | 2 | 0.520 |
Why?
| | Meningitis, Bacterial | 1 | 2015 | 6 | 0.520 |
Why?
| | Molecular Typing | 1 | 2015 | 10 | 0.520 |
Why?
| | Cat Diseases | 1 | 2015 | 4 | 0.520 |
Why?
| | Zoonoses | 1 | 2015 | 10 | 0.520 |
Why?
| | Streptococcus | 1 | 2015 | 14 | 0.520 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2014 | 2 | 0.480 |
Why?
| | Simplexvirus | 1 | 2014 | 11 | 0.470 |
Why?
| | Clostridium Infections | 2 | 2011 | 53 | 0.460 |
Why?
| | Herpesvirus 2, Human | 1 | 2013 | 4 | 0.460 |
Why?
| | Temporal Lobe | 1 | 2014 | 70 | 0.460 |
Why?
| | Virology | 1 | 2013 | 6 | 0.460 |
Why?
| | Herpesvirus 1, Human | 1 | 2013 | 15 | 0.450 |
Why?
| | Aphasia | 1 | 2014 | 32 | 0.450 |
Why?
| | Herpes Simplex | 1 | 2013 | 21 | 0.450 |
Why?
| | Chromatography, Affinity | 1 | 2013 | 38 | 0.450 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 19 | 0.440 |
Why?
| | Gels | 1 | 2013 | 20 | 0.440 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 47 | 0.430 |
Why?
| | Pseudomonas aeruginosa | 1 | 2013 | 71 | 0.430 |
Why?
| | Adolescent | 10 | 2022 | 6417 | 0.420 |
Why?
| | Female | 15 | 2024 | 26576 | 0.420 |
Why?
| | Arkansas | 3 | 2024 | 1990 | 0.410 |
Why?
| | Influenza, Human | 1 | 2013 | 83 | 0.410 |
Why?
| | Disease Outbreaks | 1 | 2013 | 123 | 0.410 |
Why?
| | Polymerase Chain Reaction | 4 | 2015 | 456 | 0.400 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2011 | 14 | 0.400 |
Why?
| | Antigens, Bacterial | 1 | 2011 | 54 | 0.390 |
Why?
| | Immunoenzyme Techniques | 1 | 2011 | 141 | 0.390 |
Why?
| | Adult | 11 | 2022 | 13356 | 0.390 |
Why?
| | Bacterial Toxins | 1 | 2011 | 51 | 0.380 |
Why?
| | Infant, Newborn | 5 | 2024 | 2729 | 0.370 |
Why?
| | Young Adult | 7 | 2022 | 4031 | 0.360 |
Why?
| | Sequence Analysis, DNA | 2 | 2008 | 237 | 0.350 |
Why?
| | Male | 12 | 2024 | 25454 | 0.330 |
Why?
| | Candida | 2 | 2014 | 60 | 0.320 |
Why?
| | Mass Screening | 1 | 2012 | 346 | 0.320 |
Why?
| | DNA, Fungal | 1 | 2008 | 43 | 0.300 |
Why?
| | Nervous System Neoplasms | 1 | 2007 | 5 | 0.290 |
Why?
| | Nerve Sheath Neoplasms | 1 | 2007 | 21 | 0.290 |
Why?
| | Candidiasis | 1 | 2008 | 114 | 0.290 |
Why?
| | Diagnosis, Differential | 4 | 2017 | 1037 | 0.270 |
Why?
| | Postoperative Complications | 1 | 2013 | 1018 | 0.260 |
Why?
| | Rib Fractures | 1 | 2006 | 1 | 0.260 |
Why?
| | Myelolipoma | 1 | 2006 | 9 | 0.260 |
Why?
| | Burkholderia gladioli | 1 | 2005 | 1 | 0.260 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2005 | 4 | 0.260 |
Why?
| | Burkholderia Infections | 1 | 2005 | 4 | 0.260 |
Why?
| | Rectum | 2 | 2019 | 52 | 0.260 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2006 | 52 | 0.250 |
Why?
| | Middle Aged | 7 | 2017 | 12293 | 0.240 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2004 | 2 | 0.230 |
Why?
| | Osteomyelitis | 1 | 2005 | 125 | 0.230 |
Why?
| | Gene Deletion | 1 | 2024 | 267 | 0.220 |
Why?
| | Abdominal Pain | 1 | 2004 | 84 | 0.220 |
Why?
| | Streptococcus pyogenes | 1 | 2022 | 18 | 0.210 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 33 | 0.210 |
Why?
| | Seroepidemiologic Studies | 1 | 2022 | 51 | 0.200 |
Why?
| | Aged, 80 and over | 3 | 2015 | 3138 | 0.200 |
Why?
| | Quarantine | 1 | 2022 | 12 | 0.200 |
Why?
| | Antibodies, Viral | 1 | 2022 | 94 | 0.200 |
Why?
| | Aged | 5 | 2017 | 9449 | 0.200 |
Why?
| | Bordetella | 1 | 2020 | 1 | 0.190 |
Why?
| | Bordetella Infections | 1 | 2020 | 1 | 0.190 |
Why?
| | Bordetella parapertussis | 1 | 2020 | 1 | 0.190 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 77 | 0.180 |
Why?
| | Whooping Cough | 1 | 2020 | 11 | 0.180 |
Why?
| | Air Microbiology | 1 | 2020 | 12 | 0.180 |
Why?
| | Pregnancy | 3 | 2020 | 2468 | 0.180 |
Why?
| | Feces | 2 | 2011 | 131 | 0.180 |
Why?
| | Adenoidectomy | 1 | 2020 | 35 | 0.180 |
Why?
| | Prospective Studies | 4 | 2020 | 2345 | 0.180 |
Why?
| | Tonsillectomy | 1 | 2020 | 47 | 0.180 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 51 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2020 | 114 | 0.170 |
Why?
| | Asia, Southeastern | 1 | 2017 | 5 | 0.150 |
Why?
| | Plasmodium falciparum | 1 | 2017 | 19 | 0.150 |
Why?
| | False Positive Reactions | 1 | 2017 | 60 | 0.150 |
Why?
| | Viral Load | 1 | 2017 | 76 | 0.140 |
Why?
| | Staining and Labeling | 1 | 2017 | 97 | 0.140 |
Why?
| | DNA, Viral | 1 | 2017 | 133 | 0.140 |
Why?
| | Cats | 1 | 2015 | 79 | 0.130 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 39 | 0.130 |
Why?
| | DNA Fingerprinting | 1 | 2015 | 62 | 0.130 |
Why?
| | Family Characteristics | 1 | 2015 | 49 | 0.130 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2015 | 96 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2017 | 382 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2017 | 175 | 0.120 |
Why?
| | Biopsy | 1 | 2017 | 591 | 0.120 |
Why?
| | Kidney Diseases | 1 | 2017 | 211 | 0.120 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2014 | 1 | 0.120 |
Why?
| | Trichomonas Vaginitis | 1 | 2014 | 1 | 0.120 |
Why?
| | Vaginal Discharge | 1 | 2014 | 1 | 0.120 |
Why?
| | Microbiological Techniques | 1 | 2014 | 8 | 0.120 |
Why?
| | Vaginosis, Bacterial | 1 | 2014 | 8 | 0.120 |
Why?
| | Acyclovir | 1 | 2014 | 9 | 0.120 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 30 | 0.120 |
Why?
| | Spinal Puncture | 1 | 2014 | 16 | 0.120 |
Why?
| | Time Factors | 2 | 2015 | 2891 | 0.120 |
Why?
| | Transition Temperature | 1 | 2013 | 6 | 0.110 |
Why?
| | Fever | 1 | 2014 | 111 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 1526 | 0.110 |
Why?
| | Intraoperative Care | 1 | 2013 | 51 | 0.110 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 181 | 0.110 |
Why?
| | Operative Time | 1 | 2013 | 71 | 0.110 |
Why?
| | Echocardiography, Transesophageal | 1 | 2013 | 60 | 0.110 |
Why?
| | Antiviral Agents | 1 | 2014 | 168 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 907 | 0.100 |
Why?
| | Heart Valve Diseases | 1 | 2013 | 49 | 0.100 |
Why?
| | Kidney | 1 | 2017 | 672 | 0.100 |
Why?
| | Colonic Neoplasms | 1 | 2014 | 158 | 0.100 |
Why?
| | United States | 3 | 2020 | 4883 | 0.100 |
Why?
| | Nasopharynx | 2 | 2020 | 25 | 0.090 |
Why?
| | Cross Infection | 1 | 2011 | 94 | 0.090 |
Why?
| | Length of Stay | 1 | 2013 | 624 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2020 | 6124 | 0.080 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2007 | 111 | 0.080 |
Why?
| | Mycological Typing Techniques | 1 | 2008 | 2 | 0.080 |
Why?
| | Mucin-1 | 1 | 2007 | 3 | 0.070 |
Why?
| | Ulnar Nerve | 1 | 2007 | 3 | 0.070 |
Why?
| | Leprosy | 1 | 2007 | 6 | 0.070 |
Why?
| | Tongue | 1 | 2007 | 38 | 0.070 |
Why?
| | Base Sequence | 1 | 2008 | 657 | 0.070 |
Why?
| | Genotype | 1 | 2008 | 539 | 0.070 |
Why?
| | Bacterial Infections | 1 | 2007 | 94 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 799 | 0.070 |
Why?
| | Ossification, Heterotopic | 1 | 2006 | 8 | 0.070 |
Why?
| | Adrenal Glands | 1 | 2006 | 40 | 0.060 |
Why?
| | Bacteria | 1 | 2007 | 219 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2008 | 483 | 0.060 |
Why?
| | Phenotype | 1 | 2008 | 728 | 0.060 |
Why?
| | Adipocytes | 1 | 2006 | 121 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2007 | 649 | 0.060 |
Why?
| | Jejunal Diseases | 1 | 2004 | 3 | 0.060 |
Why?
| | Intussusception | 1 | 2004 | 10 | 0.060 |
Why?
| | Anastomosis, Surgical | 1 | 2004 | 66 | 0.060 |
Why?
| | Jejunum | 1 | 2004 | 54 | 0.060 |
Why?
| | Necrosis | 1 | 2004 | 175 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2007 | 986 | 0.050 |
Why?
| | Ischemia | 1 | 2004 | 153 | 0.050 |
Why?
| | Blood Cells | 1 | 2002 | 43 | 0.050 |
Why?
| | Plasma | 1 | 2002 | 42 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2005 | 953 | 0.050 |
Why?
| | Alcoholism | 1 | 2004 | 232 | 0.050 |
Why?
| | Bordetella pertussis | 1 | 2020 | 3 | 0.050 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2020 | 15 | 0.050 |
Why?
| | Risk Assessment | 1 | 2005 | 1255 | 0.050 |
Why?
| | Animals | 1 | 2015 | 13100 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 61 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 1 | 2006 | 1153 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2005 | 2177 | 0.040 |
Why?
| | Risk | 1 | 2020 | 314 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2005 | 742 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2020 | 679 | 0.040 |
Why?
| | Cohort Studies | 1 | 2020 | 1403 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2005 | 5178 | 0.030 |
Why?
| | Trichomonas vaginalis | 1 | 2014 | 3 | 0.030 |
Why?
| | Gardnerella vaginalis | 1 | 2014 | 2 | 0.030 |
Why?
| | Point-of-Care Systems | 1 | 2014 | 55 | 0.030 |
Why?
| | Risk Factors | 1 | 2020 | 3605 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2007 | 28 | 0.020 |
Why?
| | PubMed | 1 | 2007 | 13 | 0.020 |
Why?
| | Dermatitis | 1 | 2007 | 36 | 0.020 |
Why?
| | Granuloma | 1 | 2007 | 45 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2007 | 187 | 0.020 |
Why?
| | Sarcoidosis | 1 | 2007 | 44 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2007 | 234 | 0.020 |
Why?
| | Prevalence | 1 | 2007 | 956 | 0.010 |
Why?
|
|
Boyanton Jr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|